Complete Filing Data
RF Acquisition Corp II reported Stockholders Equity of -$4.59 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean RF Acquisition Corp II did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income * | $3.4M | $3.2M |
| Operating Income Loss | -$1.3M | -$361.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | $1.1M | $1.1M | $1.0M | $1.4M | $547.0K | -$60.4K |
| Operating Income Loss | -$229.7K | -$181.7K | -$213.2K | -$90.0K | -$109.7K | -$60.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$4.6M | -$3.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $337.4K | $958.8K |
| Retained Earnings Accumulated Deficit | -$4.6M | -$3.3M |
| Liabilities Current | $969.4K | $295.2K |
| Liabilities And Stockholders Equity | $52.7M | $120.1M |
| Common Stock Value | $352.00 | $352.00 |
| Assets | $52.7M | $120.1M |
| Accrued Liabilities Current | $635.2K | $81.7K |
| Temporary Equity Carrying Amount Attributable To Parent | $52.3M | $119.1M |
| Liabilities | $5.0M | $4.3M |
| Cash Equivalents At Carrying Value | $52.3M | $119.1M |
| Assets Current | $401.8K | $984.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$621.4K | $958.8K |
| Interest Earned On Cash Held In Trust Account | ||
| Deferred Underwriting Fee Payable | $4.0M | $4.0M |
| Deferred Offering Costs Included In Accrued Offerings Costs | ||
| Investment Of Cash In Trust Account | $115.6M | |
| Deferred Underwriting Fee Payables | $4.0M | |
| Deferred Offering Costs Paid Through Advances From Related Party |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.0M | -$3.7M | -$3.5M | -$3.2M | -$3.1M | -$35.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $562.2K | $626.3K | $812.3K | $986.3K | $964.8K | |
| Retained Earnings Accumulated Deficit | -$4.0M | -$3.7M | -$3.5M | -$3.2M | -$3.1M | -$60.4K |
| Liabilities Current | $526.8K | $375.5K | $403.0K | $221.9K | $167.8K | $333.1K |
| Liabilities And Stockholders Equity | $123.5M | $122.3M | $121.2M | $118.8M | $117.3M | $297.7K |
| Common Stock Value | $352.00 | $352.00 | $352.00 | $352.00 | $352.00 | $308.00 |
| Assets | $123.5M | $122.3M | $121.2M | $118.8M | $117.3M | $297.7K |
| Accrued Liabilities Current | $223.2K | $101.9K | $159.5K | $83.4K | $29.2K | $3.8K |
| Temporary Equity Carrying Amount Attributable To Parent | $122.9M | $121.6M | $120.3M | $117.7M | $116.2M | |
| Liabilities | $4.6M | $4.4M | $4.4M | $4.2M | $4.2M | |
| Cash Equivalents At Carrying Value | $122.9M | $121.6M | $120.3M | $117.7M | $116.2M | |
| Assets Current | $591.3K | $669.7K | $879.0K | $1.0M | $1.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$146.4K | |||||
| Interest Earned On Cash Held In Trust Account | $1.3M | $1.2M | $1.5M | $656.7K | ||
| Deferred Underwriting Fee Payable | $4.0M | $4.0M | $4.0M | $4.0M | ||
| Deferred Offering Costs Included In Accrued Offerings Costs | $236.1K | |||||
| Investment Of Cash In Trust Account | ||||||
| Deferred Underwriting Fee Payables | ||||||
| Deferred Offering Costs Paid Through Advances From Related Party | $61.6K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $553.5K | $166.3K |
| Net Cash Provided By Used In Operating Activities | -$561.4K | -$89.5K |
| Net Cash Provided By Used In Investing Activities | $71.5M | -$115.6M |
| Net Cash Provided By Used In Financing Activities | -$71.5M | $116.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | ||
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | $112.7M | |
| Increase Decrease In Due To Sponsor | $120.7K | $75.0K |
| Proceeds From Related Party Debt | $45.3K | |
| Proceeds From Issuance Or Sale Of Equity | $1.7K | |
| Proceeds From Issuance Of Private Placement | $4.4M | |
| Increase Decrease In Prepaid Expense | -$21.2K | $25.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $77.8K | $3.8K |
| Net Cash Provided By Used In Operating Activities | -$146.4K | |
| Net Cash Provided By Used In Investing Activities | ||
| Net Cash Provided By Used In Financing Activities | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $41.0K | |
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | ||
| Increase Decrease In Due To Sponsor | $30.0K | |
| Proceeds From Related Party Debt | ||
| Proceeds From Issuance Or Sale Of Equity | ||
| Proceeds From Issuance Of Private Placement | ||
| Increase Decrease In Prepaid Expense |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Shares Outstanding Of Redeemable Ordinary Shares | 10.6M | 7.8M |
| Diluted Weighted Average Shares Outstanding Of Redeemable Ordinary Shares | 10.6M | 7.8M |
| Diluted Net Income Per Share Redeemable Ordinary Shares | $0.24 | $0.28 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Weighted Average Shares Outstanding Of Nonredeemable Ordinary Shares | ||
| Diluted Weighted Average Shares Outstanding Of Nonredeemable Ordinary Shares | 3.5M | 3.4M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 3.5M | 3.5M |
| Common Stock Shares Issued | 3.5M | 3.5M |
| Common Stock Shares Authorized | 200.0M | 200.0M |
| Temporary Equity Shares Issued | 4.8M | 11.5M |
| Temporary Equity Redemption Price Per Share | $10.82 | $10.36 |
| Diluted Net Income Per Share Nonredeemable Ordinary Shares | $0.24 | $0.28 |
| Basic Net Income Per Share Nonredeemable Ordinary Shares | $0.24 | $0.29 |
| Diluted Net Income Loss Per Share Nonredeemable Ordinary Shares | ||
| Basic Net Income Loss Per Share Nonredeemable Ordinary Shares | ||
| Weighted Average Share Outstanding Of Nonredeemable Ordinary Shares | ||
| Weighted Average Shares Outstanding Of Nonredeemable Ordinary Share | 3.5M | 3.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Shares Outstanding Of Redeemable Ordinary Shares | 11.5M | 11.5M | 11.5M | 11.5M | 5.0M | |
| Diluted Weighted Average Shares Outstanding Of Redeemable Ordinary Shares | 11.5M | 11.5M | 11.5M | 11.5M | 5.1M | |
| Diluted Net Income Per Share Redeemable Ordinary Shares | $0.07 | $0.07 | $0.07 | $0.09 | $0.07 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Shares Outstanding Of Nonredeemable Ordinary Shares | 3.5M | 3.5M | 3.5M | 3.5M | 3.0M | 2.6M |
| Diluted Weighted Average Shares Outstanding Of Nonredeemable Ordinary Shares | 3.5M | 3.5M | 3.5M | 3.5M | 3.3M | 3.1M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.1M |
| Common Stock Shares Issued | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.1M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M |
| Temporary Equity Shares Issued | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | |
| Temporary Equity Redemption Price Per Share | $10.68 | $10.57 | $10.46 | $10.24 | $10.11 | |
| Diluted Net Income Per Share Nonredeemable Ordinary Shares | $0.07 | $0.09 | $0.07 | |||
| Basic Net Income Per Share Nonredeemable Ordinary Shares | $0.07 | $0.09 | $0.07 | |||
| Diluted Net Income Loss Per Share Nonredeemable Ordinary Shares | $0.07 | $0.07 | $0.07 | $-0.02 | ||
| Basic Net Income Loss Per Share Nonredeemable Ordinary Shares | $0.07 | $0.07 | $0.07 | $-0.02 | ||
| Weighted Average Share Outstanding Of Nonredeemable Ordinary Shares | 3.5M | 3.3M | ||||
| Weighted Average Shares Outstanding Of Nonredeemable Ordinary Share |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Basic Net Income Per Ordinary Share Redeemable Ordinary Shares | 0.24 | 0.29 |
| Advance From Related Party | $138.6K | $138.6K |
| Prepaid Expense Current | $4.4K | $25.6K |
| Operating And Formation Costs | ||
| Due To Sponsor | $195.7K | $75.0K |
| Payment Of Operating Costs Through Advance From Related Party | $31.6K | |
| Payment Of Operating Costs In Exchange For Issuance Of Founder Shares | 25.0K | |
| Issuance Of Ordinary Shares To Sponsor | 25.0K | |
| Operating Costs And Expenses | $1.3M | $361.8K |
| Interest Income Other | $4.6M | $3.5M |
| Remeasurement Of Ordinary Shares Subject To Redemption | ||
| Proceeds Received For Representative Shares To Ebc | 1.7K | |
| Fair Value Of Rights Included In Public Units | $728.0K | |
| Allocated Value Of Transaction Costs To Rights Included In Public Units | -$60.4K | |
| Payment Of Offering Costs | $498.8K | |
| Accretion For Ordinary Shares To Redemption Amount | -11.6M | |
| Sale Of Private Placement Units | $4.4M | |
| Sale Of Private Placement Unit Shares | 437.5K | |
| Remeasurement Of Ordinary Shares To Redemption Amount | -4.7M | -11.6M |
| Remeasurement Of Ordinary Shares Subject To Possible Redemption Value | 4.7M | 11.6M |
| Offering Cost Included In Advances From Related Party | $61.6K | |
| Accretion Of Ordinary Shares Subject To Possible Redemption Value | 11.6M | |
| Sale Of437500Private Placement Units |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Basic Net Income Per Ordinary Share Redeemable Ordinary Shares | 0.07 | 0.07 | 0.07 | 0.09 | 0.07 | |
| Advance From Related Party | $138.6K | $138.6K | $138.6K | $138.6K | $138.6K | $93.2K |
| Prepaid Expense Current | $29.1K | $43.4K | $66.7K | $26.6K | $55.0K | |
| Operating And Formation Costs | $181.7K | $213.2K | $90.0K | $109.7K | $60.4K | |
| Due To Sponsor | $165.0K | $135.0K | $105.0K | |||
| Payment Of Operating Costs Through Advance From Related Party | $31.6K | |||||
| Payment Of Operating Costs In Exchange For Issuance Of Founder Shares | 25.0K | |||||
| Issuance Of Ordinary Shares To Sponsor | 25.0K | |||||
| Operating Costs And Expenses | $229.7K | $90.0K | ||||
| Interest Income Other | $1.3M | $1.5M | ||||
| Remeasurement Of Ordinary Shares Subject To Redemption | 1.3M | 1.3M | 1.2M | |||
| Proceeds Received For Representative Shares To Ebc | 1.7K | |||||
| Fair Value Of Rights Included In Public Units | $728.0K | |||||
| Allocated Value Of Transaction Costs To Rights Included In Public Units | -$60.4K | |||||
| Payment Of Offering Costs | ||||||
| Accretion For Ordinary Shares To Redemption Amount | -1.5M | -8.7M | ||||
| Sale Of Private Placement Units | $4.4M | |||||
| Sale Of Private Placement Unit Shares | 437.5K | |||||
| Remeasurement Of Ordinary Shares To Redemption Amount | -1.5M | -8.7M | ||||
| Remeasurement Of Ordinary Shares Subject To Possible Redemption Value | ||||||
| Offering Cost Included In Advances From Related Party | ||||||
| Accretion Of Ordinary Shares Subject To Possible Redemption Value | ||||||
| Sale Of437500Private Placement Units | $4.4M |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.